BJH - volume 5, issue 3, september 2014
E. Macken MD, L. Lewi MD, PhD, D. Dierickx MD, PhD
A 26-year-old female was referred to our hospital in the 20th week of a second pregnancy because of severe intra-uterine growth restriction, hypertension, thrombocytopenia and proteinuria. Working diagnosis was thrombotic thrombocytopenic purpura, but it was difficult to differentiate it from haemolysis, elevated liver enzymes, and low platelet count. Therapeutic plasma exchange was urgently initiated and pregnancy was terminated with prostaglandin induction. The activity level of ADAMTS13 (a disintegrin and metalloproteinase with trombospondin type-1 motifs 13, the von Willebrand Factor cleaving protease), was immeasurably low. Furthermore, the patient was positive for ADAMTS13 inhibitor, which confirmed a diagnosis of acquired thrombotic thrombocytopenic purpura.
(BELG J HEMATOL 2014;5(3):106–9)
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
